Scientists probe bone cells in rare childhood condition
NCT ID NCT04159675
Summary
This study aims to understand how two medications—burosumab and active vitamin D—directly affect bone-forming cells. Researchers will collect bone cells from 20 children (aged 4 months to 18 years) who are already scheduled for surgery to correct premature skull bone fusion. The goal is to learn more about the biology of these cells, particularly in children with a specific bone-weakening condition, to inform future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRANIOSYNOSTOSES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de référence des craniosténoses et malformations cranio-faciales Service de neurochirurgie Pédiatrique
RECRUITINGBron, 69500, France
Contact
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.